Company profile SLDB

Solid Biosciences Inc
solid biosciences (solid) is a cambridge, ma based biotech company singularly focused on developing treatments and cures for duchenne muscular dystrophy (dmd). solid combines sharp commercial focus with world-class science to advance promising therapies and is positioned to catalyze therapeutic development across all aspects of the disease. condition-focused, our mandate is com...prehensive; improving daily life for patients and attacking the roots of dmd. Show More
Quarter analysis & expected interestLast update: November 06 2023 17:09:42.

After 34 days of this quarter the interest is at 88.0. Based on that we can calculate that during remaining 58 days it will total up to 238.0.
That appears to be equal to previous quarter and same quarter last year.

YearQ1Q2Q3Q4
2018 - - - 0
2019 0
0
0
0
2020 0
0
0
0
2021 0
0
0
0
2022 43
inf% YoY inf% QoQ
406
inf% YoY 844.2% QoQ
364
inf% YoY -10.3% QoQ
365
inf% YoY 0.3% QoQ
2023 435
911.6% YoY 19.2% QoQ
335
-17.5% YoY -23.0% QoQ
326
-10.4% YoY -2.7% QoQ
88
-75.9% YoY -73.0% QoQ
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and Solid Biosciences search interestLast update: November 06 2023 17:09:42.
Correlation coefficient between keyword and revenue is -0.43
Interest value is multiplied to fit the chart properly. Correlation level is represented by Pearson correlation coefficient. Value closer to 1 represents higher level of correlation. Value closer to -1 represents inverted relationship. Value closer to 0 represents no relationship.
Analysis of YoY 5Y Google Trends Last update: November 06 2023 17:09:43.

The average 5 years interest of Solid Biosciences was 9.08 per week.
The last year interest of Solid Biosciences compared to the last 5 years has changed by 186.56%.
This is something to be checked.
This didn't exist 5 years ago.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interestLast update: February 09 2024 06:42:35.

After 39 days of this quarter the interest is at 77.0. Based on that we can calculate that during remaining 52 days it will total up to 180.0.
That appears to be equal to previous quarter and same quarter last year.

YearQ1Q2Q3Q4
2019171
262
53.2% QoQ
258
-1.5% QoQ
358
38.8% QoQ
2020 191
11.7% YoY -46.6% QoQ
95
-63.7% YoY -50.3% QoQ
191
-26.0% YoY 101.1% QoQ
180
-49.7% YoY -5.8% QoQ
2021 387
102.6% YoY 115.0% QoQ
127
33.7% YoY -67.2% QoQ
115
-39.8% YoY -9.4% QoQ
128
-28.9% YoY 11.3% QoQ
2022 157
-59.4% YoY 22.7% QoQ
86
-32.3% YoY -45.2% QoQ
94
-18.3% YoY 9.3% QoQ
118
-7.8% YoY 25.5% QoQ
2023 148
-5.7% YoY 25.4% QoQ
151
75.6% YoY 2.0% QoQ
120
27.7% YoY -20.5% QoQ
190
61.0% YoY 58.3% QoQ
2024 77
-48.0% YoY -59.5% QoQ
- - -
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and Solid Biosciences search interestLast update: February 09 2024 06:42:35.
Correlation coefficient between keyword and revenue is 0.07
Interest value is multiplied to fit the chart properly. Correlation level is represented by Pearson correlation coefficient. Value closer to 1 represents higher level of correlation. Value closer to -1 represents inverted relationship. Value closer to 0 represents no relationship.
Analysis of YoY 5Y Google Trends Last update: February 09 2024 06:42:37.

The average 5 years interest of Solid Biosciences was 13.81 per week.
The last year interest of Solid Biosciences compared to the last 5 years has changed by -18.54%.
This is something to be checked.
The last year interest is quite lower compared to 5 years ago. It has decreased by -48.68%.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interestLast update: November 06 2023 17:10:24.

After 34 days of this quarter the interest is at 104.0. Based on that we can calculate that during remaining 58 days it will total up to 281.0.
Solid Biosciences stock expected interest is significantly higher compared to previous quarter (+264.9%) and same quarter last year (+124.8%).

YearQ1Q2Q3Q4
2018 - - - 178
2019 306
71.9% QoQ
241
-21.2% QoQ
376
56.0% QoQ
237
33.1% YoY -37.0% QoQ
2020 183
-40.2% YoY -22.8% QoQ
119
-50.6% YoY -35.0% QoQ
0
-100.0% YoY -100.0% QoQ
0
-100.0% YoY -100.0% QoQ
2021 0
-100.0% YoY -100.0% QoQ
0
-100.0% YoY -100.0% QoQ
0
-100.0% YoY -100.0% QoQ
0
-100.0% YoY -100.0% QoQ
2022 0
-100.0% YoY -100.0% QoQ
173
inf% YoY inf% QoQ
136
inf% YoY -21.4% QoQ
125
inf% YoY -8.1% QoQ
2023 147
inf% YoY 17.6% QoQ
111
-35.8% YoY -24.5% QoQ
77
-43.4% YoY -30.6% QoQ
104
-16.8% YoY 35.1% QoQ
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and Solid Biosciences stock search interestLast update: November 06 2023 17:10:23.
Correlation coefficient between keyword and revenue is -0.3
Interest value is multiplied to fit the chart properly. Correlation level is represented by Pearson correlation coefficient. Value closer to 1 represents higher level of correlation. Value closer to -1 represents inverted relationship. Value closer to 0 represents no relationship.
Analysis of YoY 5Y Google Trends Last update: November 06 2023 17:10:24.

The average 5 years interest of Solid Biosciences stock was 9.67 per week.
The last year interest of Solid Biosciences stock compared to the last 5 years has changed by -3.72%.
This is something to be checked.
The last year interest is quite lower compared to 5 years ago. It has decreased by -57.04%.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interestLast update: November 09 2023 07:52:42.

After 34 days of this quarter the interest is at 67.0. Based on that we can calculate that during remaining 58 days it will total up to 181.0.
Duchenne muscular dystrophy treatment expected interest is significantly lower compared to same quarter last year (-45.2%) but similar to previous quarter.

YearQ1Q2Q3Q4
2018 - - - 283
2019 564
99.3% QoQ
347
-38.5% QoQ
256
-26.2% QoQ
398
40.6% YoY 55.5% QoQ
2020 295
-47.7% YoY -25.9% QoQ
181
-47.8% YoY -38.6% QoQ
212
-17.2% YoY 17.1% QoQ
193
-51.5% YoY -9.0% QoQ
2021 223
-24.4% YoY 15.5% QoQ
191
5.5% YoY -14.3% QoQ
155
-26.9% YoY -18.8% QoQ
158
-18.1% YoY 1.9% QoQ
2022 211
-5.4% YoY 33.5% QoQ
288
50.8% YoY 36.5% QoQ
62
-60.0% YoY -78.5% QoQ
330
108.9% YoY 432.3% QoQ
2023 278
31.8% YoY -15.8% QoQ
267
-7.3% YoY -4.0% QoQ
255
311.3% YoY -4.5% QoQ
67
-79.7% YoY -73.7% QoQ
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and Duchenne muscular dystrophy treatment search interestLast update: November 09 2023 07:52:42.
Correlation coefficient between keyword and revenue is 0.37
Interest value is multiplied to fit the chart properly. Correlation level is represented by Pearson correlation coefficient. Value closer to 1 represents higher level of correlation. Value closer to -1 represents inverted relationship. Value closer to 0 represents no relationship.
Analysis of YoY 5Y Google Trends Last update: November 09 2023 07:52:44.

The average 5 years interest of Duchenne muscular dystrophy treatment was 19.98 per week.
The last year interest of Duchenne muscular dystrophy treatment compared to the last 5 years has changed by 6.96%.
This is something to be checked.
The last year interest is quite lower compared to 5 years ago. It has decreased by -29.12%.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for AVB-202-TT gene therapy to provide analysis

Correlation between past revenue and AVB-202-TT gene therapy search interest

There is not enough data for AVB-202-TT gene therapy to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for AVB-202-TT gene therapy to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for BAG3-mediated dilated cardiomyopathy to provide analysis

Correlation between past revenue and BAG3-mediated dilated cardiomyopathy search interest

There is not enough data for BAG3-mediated dilated cardiomyopathy to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for BAG3-mediated dilated cardiomyopathy to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for gene transfer therapy to provide analysis

Correlation between past revenue and gene transfer therapy search interest

There is not enough data for gene transfer therapy to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for gene transfer therapy to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interestLast update: November 06 2023 17:12:10.

After 34 days of this quarter the interest is at 0.0. Based on that we can calculate that during remaining 58 days it will total up to 0.0.
neuromuscular disease treatment expected interest is significantly lower compared to previous quarter (-100.0%) and same quarter last year (-100.0%).

YearQ1Q2Q3Q4
2018 - - - 46
2019 63
37.0% QoQ
204
223.8% QoQ
47
-77.0% QoQ
27
-41.3% YoY -42.6% QoQ
2020 112
77.8% YoY 314.8% QoQ
40
-80.4% YoY -64.3% QoQ
95
102.1% YoY 137.5% QoQ
25
-7.4% YoY -73.7% QoQ
2021 117
4.5% YoY 368.0% QoQ
39
-2.5% YoY -66.7% QoQ
12
-87.4% YoY -69.2% QoQ
104
316.0% YoY 766.7% QoQ
2022 106
-9.4% YoY 1.9% QoQ
113
189.7% YoY 6.6% QoQ
86
616.7% YoY -23.9% QoQ
98
-5.8% YoY 14.0% QoQ
2023 43
-59.4% YoY -56.1% QoQ
71
-37.2% YoY 65.1% QoQ
55
-36.0% YoY -22.5% QoQ
0
-100.0% YoY -100.0% QoQ
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and neuromuscular disease treatment search interestLast update: November 06 2023 17:12:10.
Correlation coefficient between keyword and revenue is 0.13
Interest value is multiplied to fit the chart properly. Correlation level is represented by Pearson correlation coefficient. Value closer to 1 represents higher level of correlation. Value closer to -1 represents inverted relationship. Value closer to 0 represents no relationship.
Analysis of YoY 5Y Google Trends Last update: November 06 2023 17:12:11.

The average 5 years interest of neuromuscular disease treatment was 5.78 per week.
The last year interest of neuromuscular disease treatment compared to the last 5 years has changed by -26.12%.
This is something to be checked.
The last year interest is quite lower compared to 5 years ago. It has decreased by -38.29%.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for cardiac disease therapy to provide analysis

Correlation between past revenue and cardiac disease therapy search interest

There is not enough data for cardiac disease therapy to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for cardiac disease therapy to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interestLast update: November 06 2023 17:12:35.

After 34 days of this quarter the interest is at 0.0. Based on that we can calculate that during remaining 58 days it will total up to 0.0.
Solid Biosciences news expected interest is significantly lower compared to previous quarter (-100.0%) and same quarter last year (-100.0%).

YearQ1Q2Q3Q4
2018 - - - 0
2019 0
0
0
0
2020 0
0
222
inf% YoY inf% QoQ
129
inf% YoY -41.9% QoQ
2021 103
inf% YoY -20.2% QoQ
153
inf% YoY 48.5% QoQ
135
-39.2% YoY -11.8% QoQ
158
22.5% YoY 17.0% QoQ
2022 204
98.1% YoY 29.1% QoQ
252
64.7% YoY 23.5% QoQ
116
-14.1% YoY -54.0% QoQ
37
-76.6% YoY -68.1% QoQ
2023 184
-9.8% YoY 397.3% QoQ
91
-63.9% YoY -50.5% QoQ
177
52.6% YoY 94.5% QoQ
0
-100.0% YoY -100.0% QoQ
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and Solid Biosciences news search interestLast update: November 06 2023 17:12:34.
Correlation coefficient between keyword and revenue is 0.6
Interest value is multiplied to fit the chart properly. Correlation level is represented by Pearson correlation coefficient. Value closer to 1 represents higher level of correlation. Value closer to -1 represents inverted relationship. Value closer to 0 represents no relationship.
Analysis of YoY 5Y Google Trends Last update: November 06 2023 17:12:35.

The average 5 years interest of Solid Biosciences news was 7.54 per week.
The last year interest of Solid Biosciences news compared to the last 5 years has changed by 15.25%.
This is something to be checked.
This didn't exist 5 years ago.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Useful links and data for SLDB
Earnings date: 2024-03-21 After close
Company name: Solid Biosciences Inc
Sector: Manufacturing
Company's website
Hypercharts
Yahoo Finance
MarketWatch
StockTwits
SEC Filings
SwaggyStocks
Latest articles

2026-05-13T14:37:22Z

Analyst Upgrades
Wedbush Maintains Outperform on Solid Biosciences, Lowers Price Target to $16

2026-05-13T13:10:56Z

Analyst Upgrades
Piper Sandler Maintains Overweight on Solid Biosciences, Raises Price Target to $18

2026-05-12T20:08:21Z

GlobeNewswire
Solid Biosciences Reports First Quarter 2026 Financial Results and Provides Business Updates

2026-05-07T12:00:00Z

GlobeNewswire
Solid Biosciences Doses First Participant in Phase 3 IMPACT DUCHENNE Clinical Trial Evaluating SGT-003 in Duchenne Muscular Dystrophy

2026-05-01T20:05:00Z

GlobeNewswire
Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

2026-04-30T12:00:00Z

GlobeNewswire
Solid Biosciences to Showcase a Large Presence at the 29th Annual Meeting of the American Society of Gene and Cell Therapy

2026-04-28T12:00:00Z

GlobeNewswire
Solid Biosciences Announces Receipt of European Commission Orphan Drug Designation for SGT-003 for the Treatment of Duchenne Muscular Dystrophy

2026-04-07T12:00:00Z

GlobeNewswire
Solid Biosciences to Participate at Upcoming Investor Conferences

2026-03-25T14:35:50Z

Analyst Upgrades
JP Morgan Maintains Overweight on Solid Biosciences, Raises Price Target to $12

2026-03-23T10:44:27Z

Analyst Upgrades
HC Wainwright & Co. Reiterates Buy on Solid Biosciences, Maintains $20 Price Target

2026-03-20T13:01:59Z

Analyst Upgrades
This Rubrik Analyst Begins Coverage On A Bullish Note; Here Are Top 4 Initiations For Friday

2026-03-20T12:40:44Z

Analyst Upgrades
Guggenheim Initiates Coverage On Solid Biosciences with Buy Rating, Announces Price Target of $26

2026-03-20T09:27:54Z

Analyst Upgrades
Needham Reiterates Buy on Solid Biosciences, Maintains $19 Price Target

2026-03-12T15:14:33Z

Analyst Upgrades
Wedbush Maintains Outperform on Solid Biosciences, Raises Price Target to $17

2026-03-11T12:49:53Z

Analyst Upgrades
Wedbush Reiterates Outperform on Solid Biosciences, Maintains $14 Price Target